GWAS |
- Adult body size ( 32376654)
- Attention deficit hyperactivity disorder (inattention symptoms) ( 32595297)
- Bipolar disorder (body mass index interaction) ( 24322204)
- Body mass index ( 25673413)
- Bone ultrasound measurement (broadband ultrasound attenuation) ( 28472463)
- Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia ( 29274321)
- Chronic bronchitis and chronic obstructive pulmonary disease ( 25241909)
- Chronic mountain sickness ( 31417607)
- Cognitive performance ( 20125193)
- Copper levels ( 26025379)
- Diastolic blood pressure ( 27841878)
- Drug-induced liver injury (flucloxacillin) ( 19483685)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098)
- Heart rate increase in response to exercise ( 29497042)
- Heart rate response to exercise ( 29769521)
- Heart rate response to recovery post exercise ( 29769521)
- Heart rate response to recovery post exercise (50 sec) ( 29497042)
- Hippocampal volume ( 25625606)
- Homeostasis model assessment of insulin resistance ( 33381925)
- Motion sickness ( 25628336)
- Neonatal cytokine/chemokine levels (maternal genetic effect) ( 30134952)
- Night sleep phenotypes ( 27126917)
- Overweight status ( 25133637)
- Parkinson's disease progression (composite) ( 33111402)
- Parkinson's disease progression (motor) ( 33111402)
- Refractive error ( 32231278)
- Response to mTOR inhibitor (rapamycin) ( 24009623)
- Serum alkaline phosphatase levels ( 33547301)
- Stearic acid (18:0) levels ( 23362303)
- Sudden cardiac arrest ( 21658281)
- Trunk fat mass ( 28552196)
- Type 1 diabetes nephropathy ( 23028342)
- White matter hyperintensity burden ( 25663218)
|
- Alzheimer's disease ( 34099642)
- Cerebrospinal fluid α-synuclein levels ( 29959729)
- Glaucoma (primary open-angle) ( 33627673)
- HDL cholesterol levels in HIV infection ( 33109212)
- Longitudinal change in brain amyloid plaque burden ( 26268530)
- Spatial processing ( 31596458)
|